Johnson & Johnson (JNJ) Other financing activities (2012 - 2026)

Johnson & Johnson (JNJ) has 13 years of Other financing activities data on file, last reported at -$588.0 million in Q1 2026.

• Quarterly Other financing activities fell 1570.0% year-over-year to -$588.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$662.0 million (down 627.47% YoY) and the FY2025 annual result came in at -$34.0 million, up 10.53% from the prior year.
• Other financing activities eased to -$588.0 million in Q1 2026 per JNJ's latest filing, from -$26.0 million in the prior quarter.
• The five-year high for Other financing activities was $186.0 million in Q3 2023, with the low at -$588.0 million in Q1 2026.
• Average Other financing activities over 5 years is -$76.8 million, with a median of -$37.5 million recorded in 2025.
• Year-over-year, Other financing activities plunged 4700.0% in 2023 and surged 138.91% in 2024.
• Johnson & Johnson's Other financing activities stood at -$138.0 million in 2022, then plunged by 178.26% to -$384.0 million in 2023, then surged by 80.47% to -$75.0 million in 2024, then surged by 65.33% to -$26.0 million in 2025, then tumbled by 2161.54% to -$588.0 million in 2026.
• Business Quant data shows JNJ's Other financing activities at -$588.0 million in Q1 2026, -$26.0 million in Q4 2025, and -$49.0 million in Q3 2025.